Psychiatry
Near Hanging: evaluation and management.
29 Nov, 2022 | 14:14h | UTCNear Hanging: evaluation and management – Chest (PDF)
Podcast | Opioid use disorder and acute pain in hospitalized patients.
29 Nov, 2022 | 14:05h | UTC#366 Opioid Use Disorder and Acute Pain in the Hospitalized Patient – The Curbsiders
SR | Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.
29 Nov, 2022 | 13:59h | UTCSummary: Reduction in the dose of antipsychotics for people with schizophrenia – Cochrane Library
SR | E-cigarettes are more effective than traditional nicotine-replacement methods in helping people quit smoking.
27 Nov, 2022 | 22:26h | UTCElectronic cigarettes for smoking cessation – Cochrane Library
News Release: E-cigarettes are more effective than nicotine-replacement therapy in helping smokers quit – University of Oxford
Commentaries:
Commentary on Twitter
Published today! Updated w/ 17 new studies @CochraneLibrary living review of #ecig to #QuitSMOKING. Now high certainty evidence nicotine #vapes help more people to quit at 6 mths+ than NRT. @CRUK_Policy funded https://t.co/68FBih1nVg pic.twitter.com/euKXCxLJLk
— CochraneTAG (@CochraneTAG) November 17, 2022
Consensus Paper | Prevention of alcohol withdrawal syndrome in the surgical ICU.
27 Nov, 2022 | 22:22h | UTC
ED-initiated buprenorphine: basics, barriers, and beyond the ED.
27 Nov, 2022 | 22:16h | UTCED-Initiated Buprenorphine: Basics, Barriers, and Beyond the ED – emDocs
SR | Pharmacological interventions for people with borderline personality disorder.
27 Nov, 2022 | 22:11h | UTCPharmacological interventions for people with borderline personality disorder – Cochrane Library
Review | Public health measures and prevention of alcohol-associated liver disease.
27 Nov, 2022 | 22:14h | UTC
Commentary from one of the authors on Twitter
Public Health Measures and Prevention of Alcohol-Associated Liver Disease @JCEH_Hepatology @LuisAntonioDiaz @FcoIdalsoaga @CokeArnold1 #LiverTwitter https://t.co/8pVLg5Kffp pic.twitter.com/OCrIYgVhJa
— Juan Pablo (JP) Arab, MD (@juanpabloarab) June 28, 2022
SR | Shared decision‐making interventions for people with mental health conditions.
27 Nov, 2022 | 22:10h | UTCShared decision‐making interventions for people with mental health conditions – Cochrane Library
Summary: Shared decision-making interventions for people with mental health conditions – Cochrane Library
RCT | One-session treatment compared with multisession CBT in children aged 7-16 years with specific phobias.
27 Nov, 2022 | 22:07h | UTC
Commentary on Twitter
One-session treatment and cognitive–behavioural therapy worked just as well as multisession cognitive–behavioural therapy for treating phobias in children and young people. It's also highly likely to be cost-saving.
Read the full report: https://t.co/i7M58yGfLv pic.twitter.com/ZEGgG4yh26
— NIHR Evidence (@NIHRevidence) November 25, 2022
M-A | Risk of cardiovascular diseases associated with medications used in ADHD.
25 Nov, 2022 | 12:16h | UTCCommentaries:
Meta-Analysis Finds ADHD Drugs Not Linked To Risk Of Cardiovascular Disease – Reporter Health
Review | Psychiatric issues among health professionals.
24 Nov, 2022 | 13:29h | UTCPsychiatric Issues Among Health Professionals – Medical Clinics of North America
SR | Pharmaceutical interventions for emotionalism after stroke.
22 Nov, 2022 | 13:24h | UTCPharmaceutical interventions for emotionalism after stroke – Cochrane Library
Post-trial follow-up | A brief intervention to prevent alcohol use can have sustained effects among high-risk adolescents.
22 Nov, 2022 | 13:08h | UTC
Commentary on Twitter
RCT: Personality-targeted school-based prevention program “Preventure” can effectively reduce alcohol-related harms up to 7 years later, showing the meaningful & sustained benefits of school-based prevention programs. @theMatilda_USyd https://t.co/HuoZZluc6I #OAResearch
— JAMA Network Open (@JAMANetworkOpen) November 17, 2022
Cohort Study | Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children.
21 Nov, 2022 | 14:33h | UTCAssociation of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in Children – JAMA Internal Medicine (link to abstract – $ for full-text)
Commentaries:
Antidepressants in Pregnancy Do Not Affect Child Neurodevelopment – HealthDay
Commentary on Twitter
https://twitter.com/JAMAInternalMed/status/1593046260440776704
M-A | Pharmacological interventions on smoking cessation.
18 Nov, 2022 | 13:12h | UTC
RCT | Extending the duration of prequit treatment with varenicline did not increase smoking abstinence rates.
17 Nov, 2022 | 12:22h | UTC
Commentary on Twitter
https://twitter.com/JAMANetworkOpen/status/1591128623947591680
M-A | The response of subgroups of patients with schizophrenia to different antipsychotic drugs.
11 Nov, 2022 | 13:13h | UTCThe response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis – The Lancet Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter (thread – click for more)
"Overall, these results suggest that the effectiveness and side-effect patterns of the [antipsychotic] drugs do not differ in the various subgroups of patients with schizophrenia."
New research Article @StefanLeucht https://t.co/sjcRN5nH0T
— The Lancet Psychiatry (@TheLancetPsych) October 11, 2022
RCT | Mindfulness-based stress reduction vs. escitalopram for the treatment of adults with anxiety disorders.
10 Nov, 2022 | 14:09h | UTCMindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial – JAMA Psychiatry (free for a limited period)
Commentaries:
Mindfulness worked as well for anxiety as drug in study – Associated Press
Meditation works as well as a popular drug to reduce anxiety, study finds – NPR
Commentary on Twitter
This randomized, controlled #anxiety disorder treatment trial comparing a standardized, evidence-based mindfulness-based intervention with pharmacotherapy and found that mindfulness based stress reduction was non-inferior to escitalopram https://t.co/P7KJQlT03g
— JAMA Psychiatry (@JAMAPsych) November 9, 2022
Cohort Study | Association of hormone therapy with depression during menopause.
9 Nov, 2022 | 12:17h | UTCCommentaries:
Expert reaction to study looking at HRT and depression during the menopause – Science Media Centre
Commentary on Twitter
Systemic hormone therapy (HT) before and during menopause is associated with higher risk of depression, especially in the years immediately after initiation; locally administered HT is associated with lower risk of depression for women ≥54 years. https://t.co/8k44K8SVtp
— JAMA Network Open (@JAMANetworkOpen) November 1, 2022
Cohort Study | Associations between childhood trauma and childhood psychiatric disorders in Brazil.
9 Nov, 2022 | 12:15h | UTCCommentary: Birth cohort study reveals the mental health burden of trauma in childhood – University of Bath
RCT | Efficacy and safety of methylphenidate and behavioral parent training for children aged 3–5 years with ADHD.
9 Nov, 2022 | 12:09h | UTCEfficacy and safety of methylphenidate and behavioural parent training for children aged 3–5 years with attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled, and sham behavioural parent training-controlled trial – The Lancet Child & Adolescent Health (link to abstract – $ for full-text)
Commentary on Twitter (thread – click for more)
Methylphenidate was effective in reducing #ADHD symptoms and improving functionality, and behavioural parent training was effective in improving functionality for preschool children with ADHD after 8 weeks of treatment.
New RCT by @gvpolanczyk & team: https://t.co/iDUhRMTno4
— The Lancet Child & Adolescent Health (@LancetChildAdol) October 26, 2022
NICE Guideline | Self-harm: assessment, management and preventing recurrence.
7 Nov, 2022 | 12:58h | UTC
Updated systematic review on cannabis and other plant-based treatments for chronic pain.
7 Nov, 2022 | 12:39h | UTCRelated:
Systematic Review: Cannabis-based products for chronic pain.
Podcast: #338 LIVE! Medical Cannabis: Is it still dope? – The Curbsiders
M-A: Birth outcomes of neonates exposed to marijuana in utero.
Cannabis-related allergies: an international overview and consensus recommendations.
Review: Cannabis-based medicines and medical cannabis for chronic neuropathic pain.
Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.
Guideline: Medical cannabis or cannabinoids for chronic pain.
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
Review: Considerations for cannabinoids in perioperative care by anesthesiologists.
Review: Cannabis-based Medicines and the Perioperative Physician
Perspective: If You Smoke Pot, Your Anesthesiologist Needs To Know
RCT | Naltrexone-bupropion and behavior therapy, alone and combined, for binge-eating disorder.
7 Nov, 2022 | 12:27h | UTCNews Release: People With Binge-eating Disorder Benefit From Specific Behavioral Therapy and Medication – Yale School of Medicine
Commentary: Behavioral Therapy Plus Naltrexone-Bupropion Combination May Reduce Binge Eating – Psychiatric News Alert